Human Growth Hormone(Yifan Pharmaceutical)

Primary objective: To study the pharmacokinetic characteristics of a single subcutaneous injection of the test preparation B06 and the reference preparation Noze® (specification: 1.5 mL: 5 mg) in healthy subjects, and to preliminarily evaluate the bioequivalence of the two preparations for subcutaneous injection. Secondary objective: To study the pharmacodynamic characteristics and safety of the test preparation B06 and the reference preparation Noze® (specification: 1.5 mL: 5 mg) in healthy subjects.